16-1204345-G-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The ENST00000569107.6(CACNA1H):​c.2338G>T​(p.Val780Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000325 in 1,584,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00032 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00033 ( 0 hom. )

Consequence

CACNA1H
ENST00000569107.6 missense

Scores

1
5
12

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.918

Publications

5 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08432433).
BP6
Variant 16-1204345-G-T is Benign according to our data. Variant chr16-1204345-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 460062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000315 (48/152254) while in subpopulation NFE AF = 0.000529 (36/68042). AF 95% confidence interval is 0.000392. There are 0 homozygotes in GnomAd4. There are 25 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 48 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000569107.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.2338G>Tp.Val780Phe
missense
Exon 10 of 35NP_066921.2
CACNA1H
NM_001005407.2
c.2338G>Tp.Val780Phe
missense
Exon 10 of 34NP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.2338G>Tp.Val780Phe
missense
Exon 10 of 35ENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.2338G>Tp.Val780Phe
missense
Exon 10 of 34ENSP00000454990.2
CACNA1H
ENST00000711493.1
c.2338G>Tp.Val780Phe
missense
Exon 10 of 34ENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.000315
AC:
48
AN:
152254
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000342
AC:
77
AN:
225054
AF XY:
0.000310
show subpopulations
Gnomad AFR exome
AF:
0.0000669
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00126
Gnomad NFE exome
AF:
0.000389
Gnomad OTH exome
AF:
0.000373
GnomAD4 exome
AF:
0.000326
AC:
467
AN:
1432562
Hom.:
0
Cov.:
32
AF XY:
0.000310
AC XY:
220
AN XY:
709212
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32726
American (AMR)
AF:
0.000241
AC:
10
AN:
41428
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24316
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39310
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82016
European-Finnish (FIN)
AF:
0.000963
AC:
49
AN:
50890
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5628
European-Non Finnish (NFE)
AF:
0.000360
AC:
395
AN:
1097192
Other (OTH)
AF:
0.000220
AC:
13
AN:
59056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
30
60
89
119
149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000315
AC:
48
AN:
152254
Hom.:
0
Cov.:
33
AF XY:
0.000336
AC XY:
25
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41470
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000529
AC:
36
AN:
68042
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000458
Hom.:
0
Bravo
AF:
0.000238
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000275
AC:
33

ClinVar

ClinVar submissions as Germline

Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
CACNA1H-related disorder (1)
-
-
1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.51
T
M_CAP
Pathogenic
0.44
D
MetaRNN
Benign
0.084
T
MetaSVM
Uncertain
0.0069
D
MutationAssessor
Benign
1.0
L
PhyloP100
0.92
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.81
N
REVEL
Uncertain
0.35
Sift
Benign
0.079
T
Sift4G
Uncertain
0.055
T
Polyphen
0.29
B
Vest4
0.27
MVP
0.54
ClinPred
0.020
T
GERP RS
3.2
Varity_R
0.14
gMVP
0.42
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60534546; hg19: chr16-1254345; API